Utah Medical Products Inkomsten in het verleden
Verleden criteriumcontroles 3/6
Utah Medical Products is de winst gegroeid met een gemiddeld jaarlijks percentage van 6%, terwijl de Medical Equipment industrie de winst jaarlijks groeide met 13.2%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 2.4% per jaar. Het rendement op eigen vermogen van Utah Medical Products is 12.3%, en het heeft een nettomarge van 34.6%.
Belangrijke informatie
6.0%
Groei van de winst
6.6%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.9% |
| Inkomstengroei | 2.4% |
| Rendement op eigen vermogen | 12.3% |
| Nettomarge | 34.6% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Aug 06
Utah Medical Products: An Attractive, But Speculative, Prospect
Mar 22Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Feb 09Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Dec 13Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Nov 23Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30
Nov 03Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295
Aug 28Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?
Mar 04Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295
Feb 10A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)
Jan 11Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29
Aug 08Utah Medical Products declares $0.29 dividend
Aug 02Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M
Jul 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
May 14Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29
Feb 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
Feb 12Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital
Sep 28Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28
Aug 06Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation
May 01Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?
Mar 26Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
Mar 02Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 11Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain
Jan 27
Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?
Jan 13Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?
Dec 29Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?
Dec 15Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?
Nov 30Utah Medical Products declares $0.285 dividend
Nov 03Opbrengsten en kosten
Hoe Utah Medical Products geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 44 | 15 | 8 | 1 |
| 30 Jun 24 | 47 | 16 | 9 | 1 |
| 31 Mar 24 | 49 | 16 | 10 | 1 |
| 31 Dec 23 | 50 | 17 | 11 | 1 |
| 30 Sep 23 | 51 | 17 | 12 | 1 |
| 30 Jun 23 | 52 | 17 | 11 | 1 |
| 31 Mar 23 | 52 | 17 | 11 | 1 |
| 31 Dec 22 | 52 | 16 | 11 | 0 |
| 30 Sep 22 | 52 | 16 | 12 | 1 |
| 30 Jun 22 | 51 | 16 | 11 | 1 |
| 31 Mar 22 | 50 | 15 | 11 | 1 |
| 31 Dec 21 | 49 | 15 | 12 | 1 |
| 30 Sep 21 | 48 | 14 | 12 | 0 |
| 30 Jun 21 | 46 | 13 | 11 | 0 |
| 31 Mar 21 | 42 | 11 | 11 | 0 |
| 31 Dec 20 | 42 | 11 | 11 | 0 |
| 30 Sep 20 | 42 | 12 | 11 | 1 |
| 30 Jun 20 | 44 | 13 | 12 | 1 |
| 31 Mar 20 | 47 | 15 | 12 | 1 |
| 31 Dec 19 | 47 | 15 | 11 | 0 |
| 30 Sep 19 | 45 | 14 | 10 | 0 |
| 30 Jun 19 | 43 | 17 | 9 | 0 |
| 31 Mar 19 | 42 | 18 | 8 | 0 |
| 31 Dec 18 | 42 | 19 | 7 | 0 |
| 30 Sep 18 | 42 | 13 | 7 | 0 |
| 30 Jun 18 | 42 | 10 | 7 | 0 |
| 31 Mar 18 | 42 | 9 | 7 | 0 |
| 31 Dec 17 | 41 | 9 | 7 | 0 |
| 30 Sep 17 | 40 | 14 | 7 | 0 |
| 30 Jun 17 | 40 | 13 | 7 | 0 |
| 31 Mar 17 | 39 | 12 | 7 | 0 |
| 31 Dec 16 | 39 | 12 | 7 | 0 |
| 30 Sep 16 | 40 | 13 | 7 | 0 |
| 30 Jun 16 | 40 | 13 | 8 | 0 |
| 31 Mar 16 | 40 | 12 | 8 | 0 |
| 31 Dec 15 | 40 | 12 | 8 | 1 |
| 30 Sep 15 | 41 | 12 | 8 | 1 |
| 30 Jun 15 | 41 | 11 | 8 | 1 |
| 31 Mar 15 | 41 | 11 | 8 | 0 |
| 31 Dec 14 | 41 | 11 | 8 | 0 |
| 30 Sep 14 | 41 | 12 | 9 | 0 |
| 30 Jun 14 | 40 | 12 | 9 | 0 |
| 31 Mar 14 | 40 | 11 | 9 | 0 |
| 31 Dec 13 | 40 | 11 | 9 | 0 |
Kwaliteitswinsten: UTMD heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (34.6%) UTMD } zijn hoger dan vorig jaar (32.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van UTMD is de afgelopen 5 jaar met 6% per jaar gegroeid.
Versnelling van de groei: De winstgroei UTMD is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.
Winst versus industrie: UTMD had het afgelopen jaar een negatieve winstgroei ( -9.7% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Medical Equipment ( 11.7% ).
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 12.3% ) van UTMD wordt als laag beschouwd.